VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.590
-0.005 (-0.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.585
-0.005 (-0.88%)
After-hours: Mar 9, 2026, 5:28 PM EDT
VYNE Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -26.48 | -39.83 | -28.45 | -23.21 | -73.33 | |
| Depreciation & Amortization | 0.02 | 0 | - | 0.07 | 0.11 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.28 | 0.09 | |
| Loss (Gain) From Sale of Investments | -0.78 | -2.44 | -0.26 | - | - | |
| Stock-Based Compensation | 2.31 | 3.3 | 3.31 | 4.3 | 8.08 | |
| Other Operating Activities | - | -0 | 0 | - | 3.9 | |
| Change in Accounts Receivable | 4.21 | -0.9 | 0.41 | 11.21 | 7.71 | |
| Change in Inventory | - | - | - | 0.1 | 0.11 | |
| Change in Accounts Payable | -12.31 | 6.01 | -0.56 | -8.68 | -2.68 | |
| Change in Other Net Operating Assets | -0.1 | -0.11 | 0.21 | -0.35 | -0.37 | |
| Operating Cash Flow | -33.12 | -33.97 | -25.34 | -29.2 | -56.37 | |
| Capital Expenditures | - | -0.12 | - | - | - | |
| Investment in Securities | 37.37 | 23.48 | -62.35 | - | 1.03 | |
| Other Investing Activities | - | - | 5 | 15.67 | - | |
| Investing Cash Flow | 37.37 | 23.37 | -57.35 | 15.67 | 1.03 | |
| Long-Term Debt Repaid | - | - | - | - | -36.43 | |
| Net Debt Issued (Repaid) | - | - | - | - | -36.43 | |
| Issuance of Common Stock | - | - | 82.82 | 1.47 | 76.5 | |
| Repurchase of Common Stock | -0.14 | -0.14 | -0.07 | -0.03 | -0.29 | |
| Financing Cash Flow | -0.14 | -0.14 | 82.39 | 1.65 | 39.78 | |
| Net Cash Flow | 4.1 | -10.75 | -0.3 | -11.88 | -15.56 | |
| Free Cash Flow | -33.12 | -34.09 | -25.34 | -29.2 | -56.37 | |
| Free Cash Flow Margin | -5811.23% | -6804.19% | -5976.65% | -6121.59% | -6054.46% | |
| Free Cash Flow Per Share | -0.78 | -0.80 | -2.47 | -9.16 | -19.72 | |
| Cash Interest Paid | - | - | - | - | 2.39 | |
| Levered Free Cash Flow | -26.67 | -17 | -12.25 | -11.86 | -15.97 | |
| Unlevered Free Cash Flow | -26.67 | -17 | -12.25 | -11.86 | -12.47 | |
| Change in Working Capital | -8.19 | 5 | 0.06 | 2.28 | 4.78 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.